Retour
Fourchette du Jour
0,11 €
0,11 €
Fourchette 52 Semaines
0,05 €
0,11 €
Volume
15 000
Moyenne 50J / 200J
0,11 €
/
0,10 €
Clôture Précédente
0,11 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -9,2 | 0,3 |
| P/B | — | 3,0 |
| ROE % | — | 3,7 |
| Net Margin % | -72,9 | 3,8 |
| Rev Growth 5Y % | -2,7 | 10,0 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
0,01 €
0,01 € – 0,01 €
|
253,06M | 1 |
| FY2026 |
-0,01 €
-0,01 € – -0,01 €
|
66,54M | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-12-11 | N/A | -0,01 € | — |
| 2025-03-31 | N/A | 0,00 € | — |
| 2024-11-06 | -0,01 € | -0,01 € | +0,8% |
| 2024-03-27 | N/A | -0,01 € | — |
| 2023-06-30 | -0,01 € | -0,03 € | -153,8% |
| 2022-12-31 | -0,01 € | -0,01 € | -30,5% |
| 2022-06-30 | -0,01 € | -0,02 € | -72,0% |
| 2021-12-31 | N/A | 0,01 € | — |
Dividend History
Yield
0,00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue declined -2,71% annually over 5 years
Negative free cash flow of -43,90M
PEG of 0,25 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 39,60%
Capital efficient — spends only 5,93% of revenue on capex
Croissance
Revenue Growth (5Y)
-2,71%
Revenue (1Y)36,89%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROIC-98,76%
Net Margin-72,91%
Op. Margin-37,27%
Sécurité
Debt / Equity
N/A
Current Ratio0,93
Interest Coverage-4,21
Valorisation
P/E Ratio
-9,16
Forward P/EN/A
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 36,89% | Revenue Growth (3Y) | 12,61% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -2,71% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 75,56M | Net Income (TTM) | -55,09M |
| ROE | N/A | ROA | -81,57% |
| Gross Margin | 45,65% | Operating Margin | -37,27% |
| Net Margin | -72,91% | Free Cash Flow (TTM) | -43,90M |
| ROIC | -98,76% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,93 |
| Interest Coverage | -4,21 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -9,16 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 6,68 |
| PEG Ratio | 0,25 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -8,70% | ||
| Market Cap | 504,57M | Enterprise Value | 547,10M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 75,56M | 55,20M | 59,59M | 72,77M | 84,33M |
| Net Income | -55,09M | -40,22M | -43,07M | -13,78M | 2,89M |
| EPS (Diluted) | -0,01 | -0,01 | -0,04 | -0,01 | 0,00 |
| Gross Profit | 34,50M | 29,74M | 33,25M | 49,51M | 62,23M |
| Operating Income | -28,16M | -35,26M | -39,65M | -12,25M | 4,03M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 67,54M | 64,83M | 66,77M | 73,58M | 88,09M |
| Total Liabilities | 131,43M | 61,12M | 64,70M | 35,18M | 39,55M |
| Shareholders' Equity | -38,70M | 3,71M | 2,07M | 37,77M | 48,54M |
| Total Debt | 60,09M | 30,99M | 35,99M | 10,53M | 11,17M |
| Cash & Equivalents | 17,56M | 12,72M | 14,65M | 20,52M | 40,27M |
| Current Assets | 34,68M | 33,48M | 33,53M | 42,39M | 57,86M |
| Current Liabilities | 37,33M | 20,55M | 18,57M | 17,80M | 18,23M |